Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amplified Sciences, AstraZeneca, Caristo Diagnostics, Neurometrix, Ophthalmic Surgical Solutions, Tempus Labs, Vantage Surgical Solutions, Verve Medical.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abionyx, Adial, Genentech, Hansa, Lupin, Pulmatrix, Quralis, Renibus, Roche, Salarius.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Argenx, Astellas, Avrobio, Cytodyn, Iveric, Liminal, Raya, Theratechnologies.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Argenx, Ascentage, Astellas, Astrazeneca, Ausper, Ausperbio, Drug Farm, Harbour, Iaso, Innovent, Invivyd, Kazia, Moderna, Recce, Sihuan, Skyline, Specialised, Transcenta, Xuanzhu, Zai Lab.
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Aimed, Alvotech, Amgen, Beigene, Biocon, Biocytogen, Boehringer Ingelheim, Celltrion, Chime, Coherus, Edirna, Fresenius Kabi, Fresenius SE, Genequantum, Hong-Kong King Friend Industry, Huadong Medicine, Innovent, Leaderna, Leads, Lipigon, Meitheal, Organon, Pheon, Remegen, Samsung Bioepis, Sandoz, Sanyou, Shionogi, Sirnaomics, SK Bioscience, Xentria, Zymedi.